Shingles is significantly more dangerous for older adults than for younger people, and the risks climb steeply after age 60. While shingles itself is rarely fatal (fewer than 100 people die from it each year in the U.S.), the complications it triggers in elderly patients can cause lasting nerve pain, vision loss, increased cardiovascular risk, and a serious decline in independence and quality of life.
Why Older Adults Face Greater Risk
The virus that causes shingles, varicella zoster, has been dormant in your nerve cells since you had chickenpox, sometimes decades earlier. Your immune system normally keeps it suppressed. But as you age, the branch of immunity responsible for controlling viruses weakens considerably. Research published in JAMA Internal Medicine found that the immune cells tasked with fighting varicella zoster remain effective until around age 60, after which their response often drops to levels seen in people who were never exposed to the virus at all.
This age-related immune decline means the virus reactivates more easily, replicates more aggressively, and causes more damage to nerve tissue before the body can mount a defense. That’s why about one in three people will develop shingles in their lifetime, and why the overwhelming majority of serious complications occur in adults over 60.
Postherpetic Neuralgia: The Most Common Complication
The complication most likely to affect older adults is postherpetic neuralgia, or PHN, a condition where burning, stabbing nerve pain persists long after the rash has healed. Among shingles patients aged 50 and older, roughly 12.5% develop PHN. The risk increases further with age: by age 85, it affects an estimated one in two people who get shingles.
PHN pain can last weeks, months, years, or in some cases the rest of a person’s life. It often interferes with sleep, daily activities, and social engagement. Medications used to manage it, such as certain anticonvulsants, can cause dizziness in older adults, raising the risk of falls. This creates a difficult tradeoff where treating the pain introduces new physical dangers.
Vision Loss From Shingles Near the Eye
When shingles appears on the forehead or around the eye (a form called herpes zoster ophthalmicus), it can damage the cornea, optic nerve, or other structures. A study in Investigative Ophthalmology & Visual Science tracked long-term outcomes and found that about 9.6% of affected eyes developed moderate vision loss directly caused by the infection, while 3.6% experienced severe vision loss. For an older adult already dealing with age-related eye conditions, this can mean the difference between living independently and needing daily assistance.
Increased Heart Attack and Stroke Risk
One of the less well-known dangers is what shingles does to the cardiovascular system. An analysis of more than 200,000 adults, highlighted by the National Heart, Lung, and Blood Institute, found that people who had shingles faced a nearly 30% increased risk of a future cardiovascular event like a heart attack or stroke. The inflammation triggered by the viral reactivation appears to affect blood vessels, and for older adults who already have elevated cardiovascular risk, this added burden is meaningful.
Rare but Serious: Brain and Nervous System Infections
In uncommon cases, the reactivated virus can travel into the central nervous system and cause meningitis (inflammation of the membranes surrounding the brain and spinal cord) or encephalitis (inflammation of the brain itself). These complications can produce confusion, impaired consciousness, headaches, and fever. CDC surveillance data from Japan identified varicella zoster as the most commonly detected virus in cerebrospinal fluid samples from patients with suspected central nervous system infections, accounting for about 10% of cases tested.
Disseminated zoster is another rare but serious possibility, where the rash spreads far beyond its usual single stripe on one side of the body. In severe cases it can affect the lungs, liver, or brain. This form occurs primarily in people with significantly weakened immune systems, including older adults undergoing cancer treatment or taking immunosuppressive medications.
How Shingles Affects Daily Life in Older Adults
Beyond the specific medical complications, shingles can erode an older person’s ability to function day to day. The acute rash phase typically lasts two to four weeks, but for many elderly patients the recovery period stretches much longer. Pain and fatigue can limit mobility, disrupt sleep, and lead to social withdrawal. For someone already managing other chronic conditions, a shingles episode can trigger a cascade of setbacks: reduced physical activity leads to deconditioning, which increases fall risk, which can lead to hospitalization.
Roughly 1 to 4% of all shingles patients are hospitalized for complications, and older adults make up a disproportionate share of that group. Almost all shingles-related deaths occur in older adults or people with compromised immune systems.
Why the 72-Hour Treatment Window Matters
Antiviral treatment can shorten the illness and reduce the risk of complications, but it has a narrow window of effectiveness. Treatment needs to start within 72 hours of the first symptoms appearing. After that point, antivirals are generally no longer effective at reducing symptom duration or preventing complications like PHN.
This makes early recognition critical. The earliest signs of shingles are often tingling, burning, or pain on one side of the body, sometimes appearing days before the characteristic blistering rash shows up. For older adults, any unexplained one-sided pain or sensitivity, especially in a band-like pattern on the torso, face, or neck, warrants prompt medical attention. Getting treated within that first 72 hours can meaningfully change the course of the illness.
Vaccination as Prevention
The recombinant shingles vaccine (Shingrix) is recommended for adults 50 and older and is given as two doses, two to six months apart. Clinical trials showed it to be highly effective at preventing shingles and PHN across age groups, including adults in their 70s and 80s. Unlike the older live vaccine it replaced, Shingrix maintains strong protection even in the age groups most vulnerable to complications. It is also recommended for people who have already had shingles, since the virus can reactivate more than once.